IP Library Granted Patent US 12,339,280
Granted Patent B2
US 12,339,280 · App. 17/551,055 · Granted Jun 24, 2025

N-acetyl-D-glucosamine for enhanced specificity of strep a immunoassay

Inventors: Peter Yan-Guo Ren (San Diego, CA); Jason Mcclure (San Diego, CA); Kevin S. Richardson (San Diego, CA)
Assignee: Ortho-Clinical Diagnostics, Inc.
G01N33/56944G01N33/54388G01N33/54393
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,339,280
App. No.
17/551,055
Granted
Jun 24, 2025
Kind
B2
Abstract

Methods, compositions and kits for detecting Group A Streptococcus in a biological sample are described. More particularly, the present disclosure provides an immunoassay in which the specificity of detection of Group A Streptococcus is enhanced by addition of N-acetyl-D-glucosamine. These methods, compositions and kits are useful in convenient, reliable and early diagnosis of streptococcal infection in a human subject.

Claims (30)

1. A kit, comprising:

a device comprising:

a matrix comprising (i) a sample receiving zone, (ii) a labeling zone containing a labeled antibody with specific binding to Group A Streptococcus antigen, to form a labeled antibody-bound antigen, and (iii) a capture zone having means for specifically binding the antibody-bound antigen thereon, wherein the sample receiving zone, the labeling zone and the capture zone are arranged on the matrix in a liquid flow path; and

a container comprising an extraction reagent;

wherein at least one of the sample receiving zone, the labeling zone, or the extraction reagent, comprises N-acetyl-D-glucosamine (NAG) monomer.

2. The kit of claim 1 , wherein the extraction reagent comprises NAG monomer.

3. The kit of claim 2 , wherein the container comprising the extraction reagent is configured to receive a biological sample to provide a treated sample.

4. The kit of claim 3 , further comprising a dropper tip configured to fit securely on the container comprising the extraction reagent after the container receives the biological sample.

5. The kit of claim 1 , wherein the sample receiving zone comprises NAG monomer.

6. The kit of claim 1 , wherein the labeling zone comprises NAG monomer.

7. The kit of claim 1 , wherein the NAG monomer reduces the rate of false positives for providing accurate detection of Group A Streptococcus infection.

8. The kit of claim 1 , wherein the antibody is fluorescently labeled.

9. The kit of claim 1 , further comprising an instrument for collecting a biological sample.

10. The kit of claim 9 , wherein in instrument is a swab.

11. The kit of claim 1 , further comprising instructions for use.

12. The kit of claim 11 , wherein the instructions do not caution to not touch the tongue, sides or top of mouth with the instrument when collecting the biological sample.

13. The kit of claim 1 , further comprising reference samples.

14. The kit of claim 13 , wherein the reference sample is a positive control swab coated with heat-inactivated, non-infectious Group A Streptococcus.

15. The kit of claim 13 , wherein the reference sample is a negative control swab that was coated with heat-inactivated, non-infectious Group C Streptococcus.

16. The kit of claim 1 , wherein the device comprises a lateral flow immunoassay test strip housed in a cassette.

17. A method for detecting the presence or absence of Group A Streptococcus in a biological sample, comprising:

providing a kit according to claim 1 ;

placing a biological sample in the extraction reagent to form a treated sample;

placing the treated sample on the sample receiving zone of the device; and

determining the presence or absence of Group A Streptococcus.

18. The method of claim 17 , further comprising:

providing an instrument for collecting the biological sample; and

collecting a biological sample on the instrument.

19. The method of claim 17 , further comprising:

providing instructions for use, wherein the instructions do not caution to not touch the tongue, sides or top of mouth with the instrument when collecting the sample.

Assignments (5)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: QUIDEL CORPORATION
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 068657/0827 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2021
From: REN, PETER YAN-GUO; MCCLURE, JASON; RICHARDSON, KEVIN S.
To: QUIDEL CORPORATION
Reel/Frame 058409/0752 →
Continuity (4)
Continuation 16203498 · Nov 28, 2018
Continuation 13563542 · Jul 31, 2012
Provisional Application 61514790 · Aug 3, 2011
Related Publication 20220107315A1 · Apr 7, 2022
References Cited (37)
US 5415994A · Imrich et al. · 1995 [cited by applicant]
US 5604109A · Fischetti et al. · 1997 [cited by applicant]
US 5763262A · Wong et al. · 1998 [cited by applicant]
US 5770460A · Pawlak et al. · 1998 [cited by applicant]
US 7601546B2 · Bayliff et al. · 2009 [cited by applicant]
US 7666614B2 · Cheng et al. · 2010 [cited by applicant]
US 8617820B2 · Sankaran et al. · 2013 [cited by applicant]
US 10168329B2 · Ren et al. · 2019 [cited by applicant]
US 11674961B2 · Ren · 2023 [cited by examiner]
US 20020058027A1 · Nelson et al. · 2002 [cited by applicant]
US 20080014657A1 · Lovell · 2008 [cited by examiner]
US 20100273177A1 · Piasio et al. · 2010 [cited by applicant]
US 20130196337A1 · Ren et al. · 2013 [cited by applicant]
US 20190094221A1 · Ren et al. · 2019 [cited by applicant]
US 20200116720A1 · Ren et al. · 2020 [cited by applicant]
EP 2031392A1 · 2009 [cited by applicant]
JP H02177899A · 1990 [cited by applicant]
JP H03152466A · 1991 [cited by applicant]
JP H06018524A · 1994 [cited by applicant]
JP H07036018B · 1995 [cited by applicant]
JP H08240592A · 1996 [cited by applicant]
JP 2601498B2 · 1997 [cited by applicant]
JP 2001289852A · 2001 [cited by applicant]
WO WO1984004169A1 · 1984 [cited by applicant]
WO WO1988002781A1 · 1987 [cited by applicant]
WO WO1990010232A1 · 1990 [cited by applicant]
WO WO1995004280A1 · 1995 [cited by applicant]
WO WO1999005524A1 · 1999 [cited by applicant]
WO WO2008073895A2 · 2008 [cited by applicant]
WO WO2013019817A1 · 2013 [cited by applicant]
Uhl et al., “Comparison of LightCycler PCR, rapid antigen immunoassay, and culture for detection of group A [cited by examiner]
International Search Report from International Application No. PCT/US2012/049072, 4 pages, mailed Dec. 17, 2012, application now published as International Publication No. WO2013/019817 on Feb. 7, 2013. [cited by applicant]
Blank et al., “Overlapping humoral autoimmunity links rheumatic fever and the antiphospholipid syndrome”, Rheumatology, vol. 45, pp. 833-841 (2006). [cited by applicant]
Cunningham, “Autoimmunity and molecular mimicry in the pathogenesis of post-streptococcal heart disease”, Front Bioscl., vol. 1, pp. s533-s543 (2003). [cited by applicant]
Millipore™, “Rapid Lateral Flow Test Strips, Considerations for product development”, Lit. No. TB500EN00, Rev. B, May 2008, Printed in U.S.A., Diagnostics-08-00161, Millipore Corporation, Billerica, MA (2008). [cited by applicant]
Ohkuni, “Culturette brand ten-minute group A strep ID”, J. Japanese Assoc. Inf. Dis., vol. 59, No. 12, pp. 1204-1209 (1985) [cited by applicant]
Poulsen and Johansen, “Purification of anti streptococcus group A antibodies by affinity chromatography and isoelectric focusing”, Carlsberg Res. Commun., vol. 42, pp. 397-405 (1977). [cited by applicant]